Nodal Skip Metastasis in Esophageal Squamous Cell Carcinoma Patients Undergoing Three-Field Lymphadenectomy Feng Wang, MD, Yuzhen Zheng, MD, Zhen Wang, MD, Qingfeng Zheng, MD, Qingyuan Huang, MD, Shuoyan Liu, MD The Annals of Thoracic Surgery Volume 104, Issue 4, Pages 1187-1193 (October 2017) DOI: 10.1016/j.athoracsur.2017.03.081 Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 (A) Survival curve for the entire cohort showed a similar prognosis between patients with and without nodal skip metastasis (NSM). (B) The survival curve in the matched cohort showed a similar prognosis between patients with and without NSM. (C) The distribution of the propensity score indicated the imbalanced baseline characteristics of the entire cohort. (D) The distribution of the propensity score indicated the balanced baseline characteristics of the matched cohort. The Annals of Thoracic Surgery 2017 104, 1187-1193DOI: (10.1016/j.athoracsur.2017.03.081) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Nodal skip metastasis (NSM) is associated with a relatively poor prognosis in esophageal squamous cell carcinoma patients with solitary node metastasis. The Annals of Thoracic Surgery 2017 104, 1187-1193DOI: (10.1016/j.athoracsur.2017.03.081) Copyright © 2017 The Society of Thoracic Surgeons Terms and Conditions